Panasonic Donates a Total of 1,584 Solar Lanterns to South Africa, Swaziland, and Lesotho
24.3.2017 11:06 | Business Wire
Since 2012, Panasonic Corporation has been working on the 100 Thousand Solar Lanterns Project, a project that aims to donate a total of 100 thousand solar lanterns to the world's non-electrified areas by 2018, which is the centennial of Panasonic's foundation. As part of the effort, the company donated a total of 1,584 solar lanterns for the first time to three nonprofit organizations (NGOs) working in the three countries of the Republic of South Africa, Kingdom of Swaziland, and Kingdom of Lesotho. Today, a donation ceremony was held at the Nelson Mandela Foundation in South Africa.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170324005255/en/
By utilizing solar lanterns, children are able to learn safely (Photo: Business Wire)
The donation ceremony, held by the Nelson Mandela Foundation in South Africa, was attended by government officials from the Republic of South Africa and Shigeyuki Hiroki, Ambassador of Japan in the Republic of South Africa.
Shigeyuki Hiroki said in his speech that “We expect to further promote more effective use of donated solar lanterns in these three countries as a promising renewable energy.”
Sello Hatang, CEO of the Nelson Mandela Foundation, noted in his speech that 2018 would mark the 100th birthday of Nelson Mandela himself and said that “We are challenging to change the quality of living in South Africa. The lighting would contribute to improve daily life. The Foundation supports Panasonic's solar lantern project activities and helps people's better living by the donations of the lanterns to non-electrified areas.”
At present, approximately 1.2 billion people are living in areas without electricity*, which accounts for about 16% of the world population, of which approximately 600 million people are in African countries. Although many households in these areas without electricity use kerosene lamps for lighting, its smoke poses a health hazard and exposes people to the risk of fire.
By utilizing solar lanterns, children will be able to learn safely and women's groups can engage in activities that create income at night in the community, which will help them improve their lives and help a sustainable society. Moreover, this reduces the economic burden of fuel purchase costs.
In order to contribute to resolving these social issues, Panasonic has been promoting corporate social responsibility (corporate citizenship activities) by proactively using the company's core technologies and products, and as part of this, has been implementing the 100 Thousand Solar Lanterns Project. This donation activity is an initiative to contribute to the global goals of Poverty, Health Care and Welfare, Education, Energy, etc. that constitute the Sustainable Development Goals (SDGs) put into effect by the United Nations in 2016.
Through this project, the company has donated a total of approximately 81,000 units to 19 countries so far. In Africa, about 15,000 units have been donated already to 10 countries through international organizations and NGOs. This donation to three African countries now makes the total of donated lanterns approximately 83,000 units to 22 countries, and among them, about 16,000 units have been delivered to 13 African countries.
In addition, at the Sasol Solar Challenge, a solar car race held in South Africa last year, a solar car team from Tokai University equipped with Panasonic's solar cell module HIT(R) and a high-capacity lithium-ion battery finished second after completing 4,544.2 km.
Panasonic will accelerate this activity until 2018, in order to deliver a better life to the people living in the regions without electricity through the 100 Thousand Solar Lantern Project utilizing the company's core products and technologies.
*Source: International Energy Agency World Energy Outlook 2016
Donations destination organization
Republic of South Africa: Nelson Mandela Foundation
Kingdom of Lesotho: Lesotho Catholic Bishops Conference
Kingdom of Swaziland: All Out Africa Foundation
100 Thousand Solar Lanterns Project
Starting with the donation in Myanmar in 2011, Panasonic has donated more than 80,000 solar lanterns to 19 countries, mainly emerging and developing countries in Asia and Africa. It has been reported that the bright light of solar lanterns facilitates medical, educational and economic activities at night and it eliminates a health hazard as well as reducing the burden of households by reducing fuel costs.
Learn more about the project at http://panasonic.co.jp/citizenship/lantern/
Panasonic Corporation is a worldwide leader in the development of diverse electronics technologies and solutions for customers in the consumer electronics, housing, automotive, enterprise solutions and device industries. Since its founding in 1918, the company has expanded globally and now operates 474 subsidiaries and 94 associated companies worldwide, recording consolidated net sales of 7.553 trillion yen for the year ended March 31, 2016. Committed to pursuing new value through innovation across divisional lines, the company uses its technologies to create a better life and a better world for its customers. To learn more about Panasonic: http://www.panasonic.com/global.
Feature Stories of 100 Thousand Solar Lanterns Project | Panasonic Newsroom Global
100 Thousand Solar Lantern Project:
Global Communications Department
Media Promotion Office
Om Business Wire
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
European Commission Grants New Indication for Soliris® (Eculizumab) for the Treatment of Patients with Refractory Generalized Myasthenia Gravis (gMG)21.8.2017 13:25 | Pressemelding
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced today that the European Commission (EC) approved the extension of the indication for Soliris® (eculizumab) to include the treatment of refractory generalized myasthenia gravis (gMG) in adults who are anti-acetylcholine receptor (AChR) antibody-positive. Soliris is the first and only complement-based therapy approved in the European Union (EU) for this ultra-rare subset of patients.1-4 Patients with refractory gMG can have difficulties walking, talking, swallowing and breathing normally despite therapies currently used for MG. Exacerbations and crises of their disease may require hospitalization and intensive care and may be life-threatening.5-7 Soliris will be launched for this new indication initially in Germany, and Alexion is evaluating launches in additional EU countries. “Patients with refractory gMG have exhausted multiple the
IntegenX Applauds the Passage of the Rapid DNA Act of 201721.8.2017 12:00 | Pressemelding
IntegenX Inc., the global market leader for Rapid DNA human identification, applauds the signing into law of S.139 and HR.510, The Rapid DNA Act of 2017. The legislation will allow law enforcement agencies, under standards and guidelines established by the FBI, to perform real-time DNA testing at time of arrest, within booking stations. Similar to how fingerprint analysis has evolved from a paper and ink practice to a point-of-action technology, DNA testing has now become possible in 90 minutes within a booking station, while a suspect is still in custody. With processing times reduced from weeks to less than two hours, the potential to identify or exonerate a suspect quickly will make a meaningful impact on law enforcement. IntegenX thanks U.S. Senate sponsor Senator Orrin Hatch (R-UT) and lead co-sponsor Senator Dianne Feinstein (D-CA) as well as House sponsor Congressman
PPG Completes COLORFUL COMMUNITIES Project at Primary School in Kecskemét, Hungary21.8.2017 08:03 | Pressemelding
PPG (NYSE:PPG) today announced the completion of a COLORFUL COMMUNITIES™ project in Kecskemét, Hungary, that helped revitalize the learning environment of the Corvin Mátyás primary school. The Colorful Communities program provides PPG volunteers and products along with financial contributions to bring color and vitality to communities where the company operates around the world, such as in Kecskemét, where the PPG automotive service team operates with 33 employees. The project brought together more than 140 PPG and community volunteers who spent three days at the school revitalizing four classrooms, four changing rooms and the playground. PPG provided more than $20,000 to assist with the project, including more than 460 liters of Héra ® Prémium waterborne interior paint and Trinát ® Aqua wate
Glennmont Partners Completes Refinancing of Sleaford Biomass Plant for £150m21.8.2017 08:00 | Pressemelding
Glennmont Partners has successfully completed the refinancing of the Sleaford Renewable Energy Plant on behalf of its dedicated clean energy fund, Glennmont Clean Energy Fund Europe I, as part of a programme of realisations of value from the Fund. Glennmont Partners is one of Europe’s largest fund managers focusing exclusively on investment in clean energy infrastructure. Glennmont raises long-term capital to invest in alternative power generation projects including wind farms, biomass power stations, solar parks and small-scale hydro power plants. The carefully selected, risk managed investments deliver sustained performance and predictable returns over periods of 10 years or more. Sleaford REP is a 40MWe straw-fired biomass plant located in Lincolnshire, UK. The plant has been in operation since 2014 and is being operated by Burmeister & Wain Scandinavian Contractor (BWSC). The
Boehringer Ingelheim: Advancing anticoagulation care with new data at ESC Congress 201721.8.2017 07:08 | Pressemelding
Boehringer Ingelheim today announced that it will present important new data on the treatment of patients with atrial fibrillation (AF) at the ESC Congress in Barcelona, Spain, 26-30 August 2017. In total, four abstracts have been accepted, investigating different aspects of AF patient treatment. The results of the RE-DUAL PCI™ trial have been selected for one of the Late Breaking Science sessions of the congress. The RE-DUAL PCI™ trial compared dual therapy with triple therapy after percutaneous coronary intervention (PCI) with stent placement in approximately 2,500 adults with atrial fibrillation. Patients were either treated with dabigatran etexilate (Pradaxa®) and a single antiplatelet agent or with the vitamin K antagonist (VKA) warfarin and two antiplatelets. The dabigatran doses investigated in this trial are the same doses which have already demonstrated effective stroke preven
Study Investigates Performance of Masimo PVi® As Part of Goal-Directed Fluid Therapy During Laparoscopic Bariatric Surgery21.8.2017 06:00 | Pressemelding
Masimo (NASDAQ: MASI) announced today the findings of a recently published study in which researchers at Firat University in Turkey evaluated the performance of Masimo PVi®, a noninvasive and continuous measurement of the dynamic changes in perfusion index (Pi) that occur during respiratory cycles, as the basis of a goal-directed fluid therapy (GDFT) protocol during laparoscopic bariatric surgery on mechanically-ventilated patients.1 In the study, Dr. Demirel and colleagues sought to evaluate whether using GDFT guided by PVi on morbidly obese patients undergoing laparoscopic Roux-en-Y gastric bypass (RYGB) surgery might result in less intravenous fluid use without compromising outcomes. They enrolled 60 patients and divided them randomly into control and GDFT groups. The control group’s fluid levels were managed by standard fluid therapy, using mean arterial pressure (MAP) and
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom